凉凉?竟被辉瑞公然“退货”!biotech暴跌60%

谈思生物
01 Jan

2025.01.01本文字数:1356,阅读时长大约4分钟导读:基因编辑巨头Sangamo遭遇辉瑞退货,股价暴跌60%,但罗氏和安斯泰来的合作为其带来转机。基因编辑技术的演进经历了数个阶段,其中最初的技术是Sangamo公司掌握关键专利的锌指核酸酶技术(ZFN)。随着CRISPR技术的兴起,加之Sangamo对ZFN技术的“独家控制”,Sangamo开始遭遇挑战。正如bioSeedin之前报道的...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10